Cite
HARVARD Citation
van Veelen, A. et al. (2021). Development and validation of an HPLC–MS/MS method to simultaneously quantify alectinib, crizotinib, erlotinib, gefitinib and osimertinib in human plasma samples, using one assay run. Biomedical chromatography. p. n/a. [Online].